Injective (INJ) traded at $8.44 on 5 November 2026, up 10.1% in 24 hours, after a Form 8-A filing disclosed that Nasdaq approved the listing of Canary Capital’s Staked INJ ETF. The filing covers the listing, not the launch. The trust’s registration became effective on 4 November, and Canary’s own fund page still showed no market price and zero net assets.